Equity awards granted to CONMED (CNMD) General Counsel Hollie Foust

Rhea-AI Filing Summary

Foust Hollie K reported acquisition or exercise transactions in this Form 4 filing.

CONMED Corp reported that its General Counsel and Corporate Secretary, Hollie K. Foust, received equity awards in the form of restricted stock units and stock options. The grant included 10,919 RSUs, each representing a right to receive one share of CONMED common stock.

The RSUs were awarded under the company’s 2025 Long-Term Incentive Plan and generally vest over three years, with 33% vesting after the first and second years and 34% after the third year. Foust was also granted 12,940 options to purchase common stock under the same plan, which generally vest in equal 25% installments over four years starting one year after the grant date.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Foust Hollie K

Role General Counsel & Corp Sec

Type	Security	Shares	Price	Value
Grant/Award	RSUs (Restricted Stock Units)	10,919	$0.00	--
Grant/Award	Options To Purchase Common Stock	12,940	$0.00	--

Holdings After Transaction: RSUs (Restricted Stock Units) — 10,919 shares (Direct); Options To Purchase Common Stock — 12,940 shares (Direct)

Footnotes (1)

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foust Hollie K

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel & Corp Sec

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	03/02/2026		A		10,919		(1)	03/02/2036	Common Stock	10,919	$0	10,919	D
Options To Purchase Common Stock	$45.79	03/02/2026		A		12,940		(2)	03/02/2036	Common Stock	12,940	$0	12,940	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

2. The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.

	/s/ Thomas Fistek for Hollie K. Foust by Power of Attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did CONMED (CNMD) grant to Hollie K. Foust?

CONMED granted Hollie K. Foust 10,919 restricted stock units and 12,940 stock options. Both awards were issued under the company’s 2025 Long-Term Incentive Plan as part of her compensation as General Counsel and Corporate Secretary.

How do the RSUs granted to Hollie K. Foust at CONMED (CNMD) vest?

The 10,919 RSUs generally vest over three years: 33% one year after the grant date, another 33% in the second year, and the remaining 34% in the third year. Each RSU represents a contingent right to receive one CONMED common share.

What are the vesting terms of Hollie K. Foust’s CONMED (CNMD) stock options?

The 12,940 stock options generally vest in four equal 25% installments. The first 25% vests one year after the grant date, with additional 25% portions vesting annually thereafter, all under CONMED’s 2025 Long-Term Incentive Plan.

Does Hollie K. Foust’s Form 4 for CONMED (CNMD) show any stock sales?

The Form 4 only reports acquisitions via grants of RSUs and stock options, with no sales disclosed. Both transactions are coded as awards under transaction code “A,” indicating grant or other acquisition rather than market purchases or dispositions.

What plan governs the new equity awards reported by CONMED (CNMD)?

Both the RSUs and stock options granted to Hollie K. Foust are issued under CONMED Corporation’s 2025 Long-Term Incentive Plan. This plan sets the terms and conditions, including the multi-year vesting schedules described in the Form 4 footnotes.